There were 1,354 press releases posted in the last 24 hours and 447,072 in the last 365 days.

Extraordinary general meeting in IDEX Biometrics held on 21 December 2023

IDEX Biometrics ASA held an extraordinary general meeting on 21 December 2023. 478.4 million shares or 34% of the capital was represented at the meeting.

All resolutions were passed as proposed in the notice of the meeting.

The consolidation of five shares into one is expected to take effect on or about 10 January 2024.

The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course.

For further information contact: 
Marianne Bøe, Head of investor relations  
E-mail: marianne.boe@idexbiometrics.com 
Tel: + 47 9180 0186 

About IDEX Biometrics 
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com 

About this notice  
This information is subject to disclosure pursuant to Euronext Oslo Børs rule book. The notice was published by Erling Svela, Vice president of finance, on 21 December 2023 at 14:30 CET on behalf of IDEX Biometrics ASA. 


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.